🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Sanofi - Q2 2026 13F Filings

SA

Sanofi

CIK: 0001121404
Address: France Paris 46 Avenue De La Grande Armee
$534.04 M
Portfolio Value
10
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 07/28/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026

Top Sells

Q2 2026

Asset Allocation

Stocks/ETFs
+58.96%
$534.04 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Sanofi Q2 2026 Filing Summary

Sanofi filed its 13F report for Q2 2026 on July 28, 2026. The portfolio totaled 534.04 M reflecting a +58.96% change from the prior quarter, spanning 10 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 2 new positions and 1 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Sanofi’s Q2 2026 Filing

Sanofi submitted their Form 13F-HR for the Q2 2026 period on 07/28/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Sanofi reported a managed portfolio value of 534.04 M, consisting of 10 individual positions.

This page displays the raw filing documents. To see which stocks Sanofi bought or sold during Q2 2026, please visit Sanofi's Portfolio Analysis page.